Research for biomarkers of inflammatory bowel disease. - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatments - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatments

Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine0 个研究点目标入组 80 人开始时间: 2015年11月27日最近更新: 2023年10月17日

试验速览

暂无简介。

•1. Patients with history of following intestinal surgery. Patients who are scheduled for following surgery. CD : enterectomy within 12 weeks prior to enrollment pouch or stoma (except rectostomy) UC : subtotal colectomy with ileorectostomy or colectomy with ileoanal pouch, Kock pouch and ileostomy 2. Patients with history of adalimumab treatment 3. Patients who had not showed initial response to infliximab before and patients with secondary failure to infliximab 10 mg/kg 4. Patients with serious infections 5. Patients with active tuberculosis 6. Patients with a history of hypersensitivity toadalimumab 7. Patients with demyelinating disease (Multiple sclerosis, etc) or with history of demyelinating disease 8. Patients with congestive heart failure 9. Patients who is determined inappropriate to participate to this study by the investigator.

发起方

Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine